Dr. Jed C. Kaminetsky, MD

Dr. Kaminetsky practices at Progressive Surgery Center in Farmingdale, New York.

Dr. Kaminetsky's NPI, 1952378598, was assigned on March 2, 2006. Dr. Kaminetsky graduated from New York University Grossman School of Medicine in 1984. Dr. Kaminetsky holds New York license 162871.

Dr. Kaminetsky's primary practice is Progressive Surgery Center, at 340 Broad Hollow Road, Farmingdale, NY 11735. The practice phone is (631) 694-0000.

Dr. Kaminetsky's primary practice is Progressive Surgery Center in Farmingdale, New York. Dr. Kaminetsky is also affiliated with Tisch Hospital. The medical group on file is Integrated Medical Professionals. Dmand AI also links Dr. Kaminetsky to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaminetsky practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Kaminetsky's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Kaminetsky is licensed in New York.

CMS data shows 49,910 Medicare services from Dr. Kaminetsky across 36 procedure codes in 2024, for 981 Medicare patients. Medicare paid $533,680 for them.

CMS counts 981 Medicare patients who saw Dr. Kaminetsky in 2024. The largest group is 75 to 84, with 441 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kaminetsky's median patient age at 68, with 5% women.

In 2024, Dr. Kaminetsky wrote 3,253 Medicare Part D claims for 659 patients. 92% of them were for generic drugs. CMS names the drug for 3,179 of them, across 22 drugs with 11 or more claims each, at $240,410 in total drug cost. In 2023, CMS named 2,865 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Kaminetsky for performance year 2024, reported as part of a group. Dr. Kaminetsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaminetsky as offering telehealth. CMS counts 23 procedures of prostate resection by Dr. Kaminetsky, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 38 papers to Dr. Kaminetsky, published from 2010 to 2024. 2018 was the busiest year, with 5. The most frequent topics are Double-Blind Method, Hypogonadism and Testosterone. Dr. Kaminetsky has published most often in J Sex Med. Dr. Kaminetsky's most frequent co-authors are Marc C. Gittelman, MD, Kenneth Allen Goldberg, MD and Irwin Goldstein, MD.

Dmand AI links Dr. Kaminetsky to 10 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Prostatic Diseases, Prostatic Hyperplasia and Color Vision Defects. Open Payments lists research payments to Dr. Kaminetsky that name 1 trial.

CMS Open Payments shows 250 general payments to Dr. Kaminetsky from 42 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 37% of the total. Antares Pharma, Inc. paid the most, $23,530. It also lists 4 research payments totaling $30,250 from 2022 to 2025, naming 1 clinical trial.

Dr. Kaminetsky graduated from New York University Grossman School of Medicine in 1984.